Neopterin and hsCRP are not correlated in gestational diabetes mellitus

References

• Lauenborg J, Hansen T, Jensen DM, et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 2004;27:1194–9
   PubMed Web of Science ®Google Scholar
• Mor G, Cardenas I, Abrahams V, et al. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011;1221:80–7
   PubMed Web of Science ®Google Scholar
• Wegmann TG, Lin H, Guilbert L, et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353–6
   PubMedGoogle Scholar
• Atègbo JM, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006;91:4137–43
   PubMed Web of Science ®Google Scholar
• Kuzmicki M, Telejko B, Zonenberg A, et al. Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes. Horm Metab Res 2008;40:556–60
   PubMed Web of Science ®Google Scholar
• Morisset AS, Dubé MC, Côté JA, et al. Circulating interleukin-6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand 2011;90:524–30
   PubMed Web of Science ®Google Scholar
• Kuzmicki M, Telejko B, Szamatowicz J, et al. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009;25:258–63
   PubMed Web of Science ®Google Scholar
• Korkmazer E, Solak N. Correlation between inflammatory markers and insulin resistance in pregnancy. J Obstet Gynaecol 2015;35:142–5
   PubMedGoogle Scholar
• Murr C, Widner B, Wirleitner B, et al. Neopterin as a marker for immune system activation. Curr Drug Metab 2002;3:175–87
   PubMed Web of Science ®Google Scholar
• Parker DC, Mielke MM, Yu Q, et al. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer’s disease. Int J Geriatr Psychiatry 2013;28:149–54
   PubMed Web of Science ®Google Scholar
• Bariş N, Erdoǧan M, Sezer E, et al. Alterations in L-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria. Acta Diabetol 2009;46:309–16
   PubMed Web of Science ®Google Scholar
• Erkenekli K, Keskin U, Uysal B, et al. Levels of neopterin and C-reactive protein in pregnant women with fetal growth restriction. J Obstet Gynaecol 2015;35:225–8
   PubMedGoogle Scholar
• Guibourdenche J, Leguy MC, Tsatsaris V. [Biology and markers of preeclampsia]. Ann Biol Clin (Paris) 2013;71:79–87
   PubMed Web of Science ®Google Scholar
• Standards of medical care in diabetes–2015: summary of revisions. Diabetes Care 2015;38:S4
   PubMed Web of Science ®Google Scholar
• Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010;63:425–33
   PubMed Web of Science ®Google Scholar
• Gabbe SG. The gestational diabetes mellitus conferences. Three are history: focus on the fourth. Diabetes Care 1998;21:B1–2
   PubMed Web of Science ®Google Scholar
• Winkler C, Wirleitner B, Schroecksnadel K, et al. Beer down-regulates activated peripheral blood mononuclear cells in vitro. Int Immunopharmacol 2006;6:390–5
   PubMed Web of Science ®Google Scholar
• Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001;26:319–29
   PubMed Web of Science ®Google Scholar
• Fuchs D, Hausen A, Reibnegger G, et al. Neopterin in clinical medicine. Lancet 1988;1:702
   PubMed Web of Science ®Google Scholar
• Schröcksnadel H, Baier-Bitterlich G, Dapunt O, et al. Decreased plasma tryptophan in pregnancy. Obstet Gynecol 1996;88:47–50
   PubMed Web of Science ®Google Scholar
• Cayci T, Akgul EO, Kurt YG, et al. Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia. Clin Chem Lab Med 2010;48:1127–31
   PubMed Web of Science ®Google Scholar
• Keskin U, Ulubay M, Kurt YG, et al. Increased neopterin level and chitotriosidase activity in pregnant women with threatened preterm labor. J Matern Fetal Neonatal Med 2015;28:1077–81
   PubMed Web of Science ®Google Scholar
• Greksova K, Parrak V, Chovancova D, et al. Procalcitonin, neopterin and C-reactive protein in diagnostics of intrauterine infection and preterm delivery. Bratisl Lek Listy 2009;110:623–6
   PubMed Web of Science ®Google Scholar
• Ipekci SH, Kebapcilar AG, Yilmaz SA, et al. Serum levels of neopterin in gestational diabetes mellitus: the relationship with Apgar scores. Arch Gynecol Obstet 2015;292:103–9
   PubMed Web of Science ®Google Scholar
• Ozgu-Erdinc AS, Yilmaz S, Yeral MI, et al. Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal Med 2015;28:1957–62
   PubMed Web of Science ®Google Scholar
• Friis CM, Paasche Roland MC, Godang K, et al. Adiposity-related inflammation: effects of pregnancy. Obesity (Silver Spring) 2013;21:E124–30
   PubMed Web of Science ®Google Scholar
• Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265:621–36
   PubMed Web of Science ®Google Scholar
• Ridker PM, Brown NJ, Vaughan DE, et al. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004;109:IV6–19
   PubMed Web of Science ®Google Scholar
• Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Anesthesiology 2008;109:14–24
   PubMed Web of Science ®Google Scholar
• Xu L, Ping F, Yin J, et al. Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, and inflammation in gestational diabetes mellitus. PLoS One 2013;8:e81615
   PubMed Web of Science ®Google Scholar
• Qiu C, Sorensen TK, Luthy DA, et al. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol 2004;18:377–84
   PubMed Web of Science ®Google Scholar
• Wolf M, Sandler L, Hsu K, et al. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003;26:819–24
   PubMed Web of Science ®Google Scholar
• Berggren EK, Roeder HA, Boggess KA, et al. First-trimester maternal serum C-reactive protein as a predictor of third-trimester impaired glucose tolerance. Reprod Sci 2015;22:90–3
   PubMed Web of Science ®Google Scholar
• Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008;29:274–81
   PubMed Web of Science ®Google Scholar
• Grossmann V, Schmitt VH, Zeller T, et al. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care 2015;38:1356–64
   PubMed Web of Science ®Google Scholar